Psychiatry & Neurology Doctors in Mcdonough, GA Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Dr. Yolanda Malone-gilbert, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2340 Patrick Henry Pkwy, Ste 225, Mcdonough, GA 30253 Phone: 770-389-8100    Fax: 770-389-3030

Piyush C Patel, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2340 Patrick Henry Pkwy, Ste 225, Mcdonough, GA 30253 Phone: 770-389-8100    Fax: 770-389-3030

Amarasinghe Amarasinghe, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2340 Patrick Henry Pkwy, Ste 225, Mcdonough, GA 30253 Phone: 770-389-8100    Fax: 770-389-3030

Cecile J Pasion-bregman, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2340 Patrick Henry Pkwy, Ste 225, Mcdonough, GA 30253 Phone: 770-389-8100    Fax: 770-389-3030

Shkeya Bellfield, PMHNP-BC Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1700 Pennsylvania Ave Ste 206, Mcdonough, GA 30253 Phone: 706-286-6889

Dr. Olaocha Beatrice Okwuadigbo, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 155 Westridge Pkwy Ste 221, Mcdonough, GA 30253 Phone: 703-403-2505

News Archive

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

Resverlogix Corp. is pleased to announce that Dr. Norman Wong, chief scientific officer of Resverlogix Corp. presented new data at the European Society of Cardiology (ESC) Congress 2015 in a poster presentation titled: "RVX-208, an orally active BET inhibitor, lowers CVD risk by activities beyond raising ApoA-I/HDL."

Understanding potential of illicit drug ketamine in treating depression

Advancing the understanding and treatment of psychiatric disorders is a principal goal of neuroscientists. As mental disorders are the leading cause of disabilities worldwide, it is concerning that there are few effective therapeutics on the market due to the lack of knowledge regarding pathophysiology.

Climate change and health policy: Expert panel to guide health professionals in the run-up to Copenhagen

Join Ian Roberts, Mike Gill and Mala Rao for an examination of health policy in relation to climate change, both in the developed and developing world, and the crucial role that health professionals have to play in the run-up to Copenhagen. They will provide practical guidance on how to influence everything from international policy to community health strategies, and you will have the opportunity to have your questions answered by our expert panel.

Medicaid expansion finds advocates, dueling candidates and roadblocks around America

The health law's Medicaid expansion - and its cost to state bottom lines - is making news among lawmakers, candidates and advocates in Kansas, Washington state, South Carolina and Arizona.

CorVel third quarter earnings per share increases 4% to $0.56

CorVel Corporation today announced earnings per share of $0.56 for the quarter ended December 31, 2010, a 4% increase compared to $0.54 in the same quarter of the prior fiscal year. Earnings per share for the nine months ended December 31, 2010 were $1.82, a 20% increase over the $1.52 earnings per share for the nine months ended December 31, 2009.

Read more Medical News

› Verified 8 days ago